Who is sponsoring the Crohn’s disease study?

Celgene Corporation is sponsoring the study. Headquartered in Summit, New Jersey, Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. Celgene is engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com.

Celgene logo